MX2019010935A - Panel de marcadores geneticos para el diagnostico de cancer colorrectal. - Google Patents

Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Info

Publication number
MX2019010935A
MX2019010935A MX2019010935A MX2019010935A MX2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A MX 2019010935 A MX2019010935 A MX 2019010935A
Authority
MX
Mexico
Prior art keywords
onset
colorectal cancer
screening
gene marker
marker panel
Prior art date
Application number
MX2019010935A
Other languages
English (en)
Inventor
Molloy Peter
Lapointe Lawrence
PADERSEN Susanne
Original Assignee
Clinical Genomics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Genomics Pty Ltd filed Critical Clinical Genomics Pty Ltd
Publication of MX2019010935A publication Critical patent/MX2019010935A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere en términos generales a un método de tamizaje para el inicio, predisposición al inicio y/o avance de neoplasia. De manera más particular, la presente invención se refiere a un método de tamizaje para el inicio, predisposición al inicio y/o avance de neoplasia mediante tamizaje respecto a cambios en los niveles de metilación de un panel de marcadores genéticos incluyendo BCAT1, IKZF1, IRF4, GRASP y/o CAHM. El método de la presente invención es útil en una gama de aplicaciones incluyendo, pero sin limitarse a, aquellas relacionadas con la diagnosis y/o monitoreo de neoplasias colorrectales, tal como adenocarcinosis colorrectal.
MX2019010935A 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal. MX2019010935A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261646174P 2012-05-11 2012-05-11

Publications (1)

Publication Number Publication Date
MX2019010935A true MX2019010935A (es) 2019-10-24

Family

ID=49549996

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014013684A MX368034B (es) 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.
MX2019010935A MX2019010935A (es) 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014013684A MX368034B (es) 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.

Country Status (15)

Country Link
US (2) US11254985B2 (es)
EP (3) EP3594366B1 (es)
JP (3) JP6742726B2 (es)
CN (1) CN104411835B (es)
AU (3) AU2013258880B2 (es)
BR (1) BR112014028122B1 (es)
CA (3) CA3152533C (es)
DK (3) DK3594366T3 (es)
ES (1) ES2749514T3 (es)
HK (1) HK1208058A1 (es)
IL (1) IL235411A0 (es)
MX (2) MX368034B (es)
NZ (1) NZ701527A (es)
WO (1) WO2013166558A1 (es)
ZA (1) ZA201408120B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024427B (zh) * 2011-08-25 2018-01-02 临床基因组学私人有限公司 结直肠和乳腺癌诊断方法中的dna甲基化
DK3594366T3 (da) * 2012-05-11 2021-09-13 Clinical Genomics Pty Ltd Diagnostisk genmarkørpanel
IL280521B (en) * 2014-06-04 2022-07-01 Quest Diagnostics Invest Inc Suspended markers for colon and rectal cancer
WO2015184498A2 (en) 2014-06-05 2015-12-10 Clinical Genomics Pty Ltd Method for methylation analysis
WO2016201365A2 (en) * 2015-06-12 2016-12-15 Visani Giuseppe Methods for treating cancers
GB201612815D0 (en) * 2016-07-25 2016-09-07 Belgian Volition Sa Novel combination test
SG11201909618TA (en) 2017-04-19 2019-11-28 Singlera Genomics Inc Compositions and methods for library construction and sequence analysis
CN109371138B (zh) * 2018-12-29 2022-10-25 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep4
AU2019200359A1 (en) * 2019-01-18 2020-09-10 Clinical Genomics Pty Ltd Screening method
CN114207153A (zh) * 2020-03-20 2022-03-18 上海鹍远健康科技有限公司 筛查结直肠瘤的方法和试剂盒

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
JPH02289917A (ja) 1990-04-25 1990-11-29 Sony Corp 回転ヘッドドラム装置
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
US6174670B1 (en) 1996-06-04 2001-01-16 University Of Utah Research Foundation Monitoring amplification of DNA during PCR
AU7164998A (en) 1997-04-28 1998-11-24 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
EP2339028A1 (en) 2001-09-14 2011-06-29 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
EP1534865A4 (en) 2002-06-26 2005-12-21 Cold Spring Harbor Lab METHODS AND COMPOSITIONS FOR DETERMINING METHYLATION PROFILES
JP3711984B2 (ja) 2003-02-14 2005-11-02 日産自動車株式会社 ハイブリッド車両の制御装置
JP4453297B2 (ja) 2003-05-27 2010-04-21 トヨタ自動車株式会社 車両用遊星歯車式多段変速機
ES2382780T3 (es) 2003-10-21 2012-06-13 Orion Genomics, Llc Procedimientos para la determinación cuantitativa de la densidad de metilación en un locus de ADN
WO2005085477A1 (en) 2004-03-02 2005-09-15 Orion Genomics Llc Differential enzymatic fragmentation by whole genome amplification
US8501403B2 (en) 2006-03-28 2013-08-06 Commonwealth Scientific And Industrial Research Organisation Amplification of DNA fragments
JP2010527577A (ja) 2006-05-22 2010-08-19 クリニカル ジェノミクス ピーティーワイ リミテッド 検出方法
US20090176215A1 (en) * 2007-02-02 2009-07-09 Orion Genomics Llc Gene methylation in prostate cancer diagnosis
US20080221056A1 (en) * 2007-02-12 2008-09-11 Johns Hopkins University Early Detection and Prognosis of Colon Cancers
WO2009043112A1 (en) 2007-10-04 2009-04-09 Commonwealth Scientific And Industrial Research Organisation Nucleic acid amplification
ES2685678T3 (es) 2007-10-23 2018-10-10 Clinical Genomics Pty Ltd Un método para el diagnóstico de neoplasias - II
EP3056576B1 (en) 2007-10-23 2019-02-13 Clinical Genomics Pty Ltd A method of diagnosing neoplasms
ES2541178T3 (es) * 2009-02-03 2015-07-16 Mdxhealth Sa Método de detección de cáncer colorrectal
WO2010135786A1 (en) 2009-05-29 2010-12-02 Clinical Genomics Pty. Ltd. A method for diagnosing neoplasms and molecules for use therein
US20130059734A1 (en) 2009-11-13 2013-03-07 Commonwealth Scientific And Industrial Research Organisation Epigenetic analysis
WO2011126768A2 (en) * 2010-03-29 2011-10-13 Mayo Foundation For Medical Education And Research Methods and materials for detecting colorectal cancer and adenoma
EP2388336A1 (en) 2010-05-19 2011-11-23 Signature Diagnostics AG Method and kits for diagnosing colorectal cancer
AU2011301770B2 (en) * 2010-09-13 2015-11-26 Clinical Genomics Pty. Ltd Epigenetic markers of colorectal cancers and diagnostic methods using the same
US10041948B2 (en) * 2010-10-12 2018-08-07 Mayo Foundation For Medical Education And Research Materials and methods for determining cancer risk
WO2012054975A1 (en) 2010-10-28 2012-05-03 Clinical Genomics Pty. Ltd. Method of microvesicle enrichment
JP2014513959A (ja) 2011-05-05 2014-06-19 クリニカル ジェノミクス ピーティーワイ リミテッド 新生物の診断方法
CN104024427B (zh) * 2011-08-25 2018-01-02 临床基因组学私人有限公司 结直肠和乳腺癌诊断方法中的dna甲基化
DK3594366T3 (da) * 2012-05-11 2021-09-13 Clinical Genomics Pty Ltd Diagnostisk genmarkørpanel
DK3608421T3 (da) 2012-05-18 2022-09-05 Clinical Genomics Pty Ltd Fremgangsmåde til screening for colorektal cancer
EP2922973B1 (en) * 2012-11-26 2019-03-20 Clinical Genomics Pty Ltd A method of detecting methylation
IL280521B (en) * 2014-06-04 2022-07-01 Quest Diagnostics Invest Inc Suspended markers for colon and rectal cancer

Also Published As

Publication number Publication date
NZ701527A (en) 2016-07-29
AU2013258880B2 (en) 2019-02-14
EP2847355B1 (en) 2019-07-10
AU2019201294B2 (en) 2021-08-19
JP2020089378A (ja) 2020-06-11
DK3594366T3 (da) 2021-09-13
CA2872867A1 (en) 2013-11-14
EP2847355A4 (en) 2016-05-25
BR112014028122B1 (pt) 2022-08-23
CA3083314A1 (en) 2013-11-14
ES2749514T3 (es) 2020-03-20
AU2021265861A1 (en) 2021-12-02
CN104411835B (zh) 2019-12-20
HK1208058A1 (en) 2016-02-19
CA3152533A1 (en) 2013-11-14
CA2872867C (en) 2020-09-15
US20150141275A1 (en) 2015-05-21
CA3152533C (en) 2023-10-17
CN104411835A (zh) 2015-03-11
MX2014013684A (es) 2015-06-10
US20220213559A1 (en) 2022-07-07
AU2013258880A1 (en) 2014-11-20
JP2018198600A (ja) 2018-12-20
JP6742726B2 (ja) 2020-08-19
US11254985B2 (en) 2022-02-22
ZA201408120B (en) 2019-11-27
AU2019201294A1 (en) 2019-03-14
IL235411A0 (en) 2014-12-31
WO2013166558A8 (en) 2014-12-11
EP3594366B1 (en) 2021-06-23
JP2015515862A (ja) 2015-06-04
EP4001436A1 (en) 2022-05-25
DK4001436T3 (da) 2024-05-27
MX368034B (es) 2019-09-17
WO2013166558A1 (en) 2013-11-14
CA3083314C (en) 2023-01-31
EP2847355A1 (en) 2015-03-18
JP6975807B2 (ja) 2021-12-01
BR112014028122A2 (es) 2017-08-15
EP3594366A1 (en) 2020-01-15
JP6837458B2 (ja) 2021-03-03
DK2847355T3 (da) 2019-10-14
EP4001436B1 (en) 2024-03-13

Similar Documents

Publication Publication Date Title
MX2019010935A (es) Panel de marcadores geneticos para el diagnostico de cancer colorrectal.
MX2017010836A (es) Panel biomarcador para la deteccion de cancer.
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
HK1200003A1 (en) Managing or improving interference between cells
HK1211360A1 (en) Systems and methods relating to network-based biomarker signatures
MX2019008212A (es) Estructuras fibrosas que comprenden particulas y metodos para fabricarlas.
MX2016000997A (es) Metodos y composiciones para detectar contaminacion bacteriana.
MY165036A (en) Compounds and compositions for modulating egfr activity
MA34058B1 (fr) Formes de rifaximine, et leurs utilisations
MX358117B (es) Métodos y ácidos nucleicos para determinar el pronóstico de un sujeto con cáncer.
MY157341A (en) Methods and compositions for treating lung cancer
IN2015DN01688A (es)
EP2892524A4 (en) PREVENTING THE RECHUTE OF PULMONARY CANCER WITH A LIPID / CISPLATIN COMPLEX
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.
IL236436A0 (en) Kits and methods for the detection of cyanide
EP3385717A3 (en) Methods of detecting prostate cancer
MX2014002436A (es) Marcadores de diagnostico.
HRP20200204T1 (hr) Uređaj za elektrolizu i postupak za upravljanje istim
WO2013132354A3 (en) Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer
MY168379A (en) Air conditioner
MY170453A (en) Etching material
WO2015066439A8 (en) Methods of treating hematological malignancies
IN2012DE00794A (es)
UA69321U (ru) (cS)-5,11,17,23-ТЕТРА-ТРЕТ.-БУТИЛ-27-ГИДРОКСИКАРБОНИЛМЕТОКСИ-25,28-ДИГИДРОКСИ-26-ПРОПОКСИКАЛИКС[4]АРЕН И (cR)-5,11,17,23-ТЕТРА-ТРЕТ-БУТИЛ-27-ГИДРОКСИКАРБОНИЛМЕТОКСИ-25,26-ДИГИДРОКСИ-28-ПРОПОКСИКАЛИКС[4]АРЕН
IN2013DE03592A (es)